Bravecto is a chewable tablet for dogs containing fluralaner. It is for the treatment and prevention of flea and tick infestations in dogs. Bravecto can also be used as part of a treatment strategy for flea allergy dermatitis (FAD)
Active Ingredients:
Fluralaner.
Indications:
For the control of tick and flea infestations on dogs for 12 weeks.
• Treats and controls existing flea and tick infestations
• Sustained control of new flea and tick infestations for 12 weeks
• Safe for use in breeding, pregnant and lactating dogs
• Aids in the control of flea allergy dermatitis
Dosage:
- For oral use only.
- Administer Bravecto at or around feeding time for maximum absorption and efficacy.
- For optimal control of flea and tick infestation, Bravecto should be administered every 12 weeks.
Bravecto chewable tablets should be administered in accordance with the following table (corresponding to a dose of 25-56 mg fluralaner/kg body weight within one weight band):
|
Bodyweight(kg) of dog |
Number and strength of tablet to be administered |
| Bravecto 112.5 mg | Bravecto 250 mg | Bravecto 500 mg | Bravecto 1000 mg | Bravecto 1400 mg | |
| 2* - 4.5 | 1 | ||||
| > 4.5 - 10 | 1 | ||||
| > 10 - 20 | 1 | ||||
| > 20 - 40 | 1 | ||||
| > 40 - 56 | 1 |
Warnings:
- Safety in puppies under 8 weeks and weighing less than 2 kg has not been established.
- Keep the product in the original packaging until use.
- Keep out of reach of children, uninformed persons and pets.
- Do not eat, drink or smoke while handling this product.
- Wash hands thoroughly with soap and water immediately after use of the product.
- Do not store with food, drinks, medication or household products.